1 Study Coverage
    1.1 IBS-C Drugs Product Introduction
    1.2 Market by Type
        1.2.1 Global IBS-C Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Linaclotide
        1.2.3 Lubiprostone
        1.2.4 Osmotic Laxatives
        1.2.5 Stimulant Laxatives
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global IBS-C Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global IBS-C Drugs Sales Estimates and Forecasts 2017-2028
    2.2 Global IBS-C Drugs Revenue Estimates and Forecasts 2017-2028
    2.3 Global IBS-C Drugs Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global IBS-C Drugs Sales by Region
        2.4.1 Global IBS-C Drugs Sales by Region (2017-2022)
        2.4.2 Global Sales IBS-C Drugs by Region (2023-2028)
    2.5 Global IBS-C Drugs Revenue by Region
        2.5.1 Global IBS-C Drugs Revenue by Region (2017-2022)
        2.5.2 Global IBS-C Drugs Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global IBS-C Drugs Sales by Manufacturers
        3.1.1 Global Top IBS-C Drugs Manufacturers by Sales (2017-2022)
        3.1.2 Global IBS-C Drugs Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of IBS-C Drugs in 2021
    3.2 Global IBS-C Drugs Revenue by Manufacturers
        3.2.1 Global IBS-C Drugs Revenue by Manufacturers (2017-2022)
        3.2.2 Global IBS-C Drugs Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by IBS-C Drugs Revenue in 2021
    3.3 Global IBS-C Drugs Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global IBS-C Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global IBS-C Drugs Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global IBS-C Drugs Sales by Type
        4.1.1 Global IBS-C Drugs Historical Sales by Type (2017-2022)
        4.1.2 Global IBS-C Drugs Forecasted Sales by Type (2023-2028)
        4.1.3 Global IBS-C Drugs Sales Market Share by Type (2017-2028)
    4.2 Global IBS-C Drugs Revenue by Type
        4.2.1 Global IBS-C Drugs Historical Revenue by Type (2017-2022)
        4.2.2 Global IBS-C Drugs Forecasted Revenue by Type (2023-2028)
        4.2.3 Global IBS-C Drugs Revenue Market Share by Type (2017-2028)
    4.3 Global IBS-C Drugs Price by Type
        4.3.1 Global IBS-C Drugs Price by Type (2017-2022)
        4.3.2 Global IBS-C Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global IBS-C Drugs Sales by Application
        5.1.1 Global IBS-C Drugs Historical Sales by Application (2017-2022)
        5.1.2 Global IBS-C Drugs Forecasted Sales by Application (2023-2028)
        5.1.3 Global IBS-C Drugs Sales Market Share by Application (2017-2028)
    5.2 Global IBS-C Drugs Revenue by Application
        5.2.1 Global IBS-C Drugs Historical Revenue by Application (2017-2022)
        5.2.2 Global IBS-C Drugs Forecasted Revenue by Application (2023-2028)
        5.2.3 Global IBS-C Drugs Revenue Market Share by Application (2017-2028)
    5.3 Global IBS-C Drugs Price by Application
        5.3.1 Global IBS-C Drugs Price by Application (2017-2022)
        5.3.2 Global IBS-C Drugs Price Forecast by Application (2023-2028)
6 North America
    6.1 North America IBS-C Drugs Market Size by Type
        6.1.1 North America IBS-C Drugs Sales by Type (2017-2028)
        6.1.2 North America IBS-C Drugs Revenue by Type (2017-2028)
    6.2 North America IBS-C Drugs Market Size by Application
        6.2.1 North America IBS-C Drugs Sales by Application (2017-2028)
        6.2.2 North America IBS-C Drugs Revenue by Application (2017-2028)
    6.3 North America IBS-C Drugs Market Size by Country
        6.3.1 North America IBS-C Drugs Sales by Country (2017-2028)
        6.3.2 North America IBS-C Drugs Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe IBS-C Drugs Market Size by Type
        7.1.1 Europe IBS-C Drugs Sales by Type (2017-2028)
        7.1.2 Europe IBS-C Drugs Revenue by Type (2017-2028)
    7.2 Europe IBS-C Drugs Market Size by Application
        7.2.1 Europe IBS-C Drugs Sales by Application (2017-2028)
        7.2.2 Europe IBS-C Drugs Revenue by Application (2017-2028)
    7.3 Europe IBS-C Drugs Market Size by Country
        7.3.1 Europe IBS-C Drugs Sales by Country (2017-2028)
        7.3.2 Europe IBS-C Drugs Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific IBS-C Drugs Market Size by Type
        8.1.1 Asia Pacific IBS-C Drugs Sales by Type (2017-2028)
        8.1.2 Asia Pacific IBS-C Drugs Revenue by Type (2017-2028)
    8.2 Asia Pacific IBS-C Drugs Market Size by Application
        8.2.1 Asia Pacific IBS-C Drugs Sales by Application (2017-2028)
        8.2.2 Asia Pacific IBS-C Drugs Revenue by Application (2017-2028)
    8.3 Asia Pacific IBS-C Drugs Market Size by Region
        8.3.1 Asia Pacific IBS-C Drugs Sales by Region (2017-2028)
        8.3.2 Asia Pacific IBS-C Drugs Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America IBS-C Drugs Market Size by Type
        9.1.1 Latin America IBS-C Drugs Sales by Type (2017-2028)
        9.1.2 Latin America IBS-C Drugs Revenue by Type (2017-2028)
    9.2 Latin America IBS-C Drugs Market Size by Application
        9.2.1 Latin America IBS-C Drugs Sales by Application (2017-2028)
        9.2.2 Latin America IBS-C Drugs Revenue by Application (2017-2028)
    9.3 Latin America IBS-C Drugs Market Size by Country
        9.3.1 Latin America IBS-C Drugs Sales by Country (2017-2028)
        9.3.2 Latin America IBS-C Drugs Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa IBS-C Drugs Market Size by Type
        10.1.1 Middle East and Africa IBS-C Drugs Sales by Type (2017-2028)
        10.1.2 Middle East and Africa IBS-C Drugs Revenue by Type (2017-2028)
    10.2 Middle East and Africa IBS-C Drugs Market Size by Application
        10.2.1 Middle East and Africa IBS-C Drugs Sales by Application (2017-2028)
        10.2.2 Middle East and Africa IBS-C Drugs Revenue by Application (2017-2028)
    10.3 Middle East and Africa IBS-C Drugs Market Size by Country
        10.3.1 Middle East and Africa IBS-C Drugs Sales by Country (2017-2028)
        10.3.2 Middle East and Africa IBS-C Drugs Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Catalent Pharmaceuticals Solutions
        11.1.1 Catalent Pharmaceuticals Solutions Corporation Information
        11.1.2 Catalent Pharmaceuticals Solutions Overview
        11.1.3 Catalent Pharmaceuticals Solutions IBS-C Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Catalent Pharmaceuticals Solutions IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Catalent Pharmaceuticals Solutions Recent Developments
    11.2 Nestle
        11.2.1 Nestle Corporation Information
        11.2.2 Nestle Overview
        11.2.3 Nestle IBS-C Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Nestle IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Nestle Recent Developments
    11.3 Abbott Laboratories
        11.3.1 Abbott Laboratories Corporation Information
        11.3.2 Abbott Laboratories Overview
        11.3.3 Abbott Laboratories IBS-C Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Abbott Laboratories IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Abbott Laboratories Recent Developments
    11.4 Synergy Pharmaceuticals
        11.4.1 Synergy Pharmaceuticals Corporation Information
        11.4.2 Synergy Pharmaceuticals Overview
        11.4.3 Synergy Pharmaceuticals IBS-C Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Synergy Pharmaceuticals IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Synergy Pharmaceuticals Recent Developments
    11.5 Sucampo Pharmaceuticals
        11.5.1 Sucampo Pharmaceuticals Corporation Information
        11.5.2 Sucampo Pharmaceuticals Overview
        11.5.3 Sucampo Pharmaceuticals IBS-C Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Sucampo Pharmaceuticals IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Sucampo Pharmaceuticals Recent Developments
    11.6 Novartis Pharma Ag
        11.6.1 Novartis Pharma Ag Corporation Information
        11.6.2 Novartis Pharma Ag Overview
        11.6.3 Novartis Pharma Ag IBS-C Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Novartis Pharma Ag IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Novartis Pharma Ag Recent Developments
    11.7 Astellas Pharmaceuticals
        11.7.1 Astellas Pharmaceuticals Corporation Information
        11.7.2 Astellas Pharmaceuticals Overview
        11.7.3 Astellas Pharmaceuticals IBS-C Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Astellas Pharmaceuticals IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Astellas Pharmaceuticals Recent Developments
    11.8 Ardelyx, Inc
        11.8.1 Ardelyx, Inc Corporation Information
        11.8.2 Ardelyx, Inc Overview
        11.8.3 Ardelyx, Inc IBS-C Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Ardelyx, Inc IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Ardelyx, Inc Recent Developments
    11.9 Synthetic Biologics, Inc
        11.9.1 Synthetic Biologics, Inc Corporation Information
        11.9.2 Synthetic Biologics, Inc Overview
        11.9.3 Synthetic Biologics, Inc IBS-C Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Synthetic Biologics, Inc IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Synthetic Biologics, Inc Recent Developments
    11.10 Teva Pharmaceutical Industries
        11.10.1 Teva Pharmaceutical Industries Corporation Information
        11.10.2 Teva Pharmaceutical Industries Overview
        11.10.3 Teva Pharmaceutical Industries IBS-C Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Teva Pharmaceutical Industries IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Teva Pharmaceutical Industries Recent Developments
    11.11 Bama-Geve, SLU
        11.11.1 Bama-Geve, SLU Corporation Information
        11.11.2 Bama-Geve, SLU Overview
        11.11.3 Bama-Geve, SLU IBS-C Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Bama-Geve, SLU IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Bama-Geve, SLU Recent Developments
    11.12 Ferring BV
        11.12.1 Ferring BV Corporation Information
        11.12.2 Ferring BV Overview
        11.12.3 Ferring BV IBS-C Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Ferring BV IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Ferring BV Recent Developments
    11.13 Ironwood Pharmaceuticals, Inc
        11.13.1 Ironwood Pharmaceuticals, Inc Corporation Information
        11.13.2 Ironwood Pharmaceuticals, Inc Overview
        11.13.3 Ironwood Pharmaceuticals, Inc IBS-C Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Ironwood Pharmaceuticals, Inc IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Ironwood Pharmaceuticals, Inc Recent Developments
    11.14 Salix Pharmaceuticals Ltd
        11.14.1 Salix Pharmaceuticals Ltd Corporation Information
        11.14.2 Salix Pharmaceuticals Ltd Overview
        11.14.3 Salix Pharmaceuticals Ltd IBS-C Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.14.4 Salix Pharmaceuticals Ltd IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 Salix Pharmaceuticals Ltd Recent Developments
    11.15 Norgine B.V
        11.15.1 Norgine B.V Corporation Information
        11.15.2 Norgine B.V Overview
        11.15.3 Norgine B.V IBS-C Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.15.4 Norgine B.V IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.15.5 Norgine B.V Recent Developments
    11.16 Prometheus Laboratories Inc
        11.16.1 Prometheus Laboratories Inc Corporation Information
        11.16.2 Prometheus Laboratories Inc Overview
        11.16.3 Prometheus Laboratories Inc IBS-C Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.16.4 Prometheus Laboratories Inc IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.16.5 Prometheus Laboratories Inc Recent Developments
    11.17 Actavis Nordic A/S
        11.17.1 Actavis Nordic A/S Corporation Information
        11.17.2 Actavis Nordic A/S Overview
        11.17.3 Actavis Nordic A/S IBS-C Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.17.4 Actavis Nordic A/S IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.17.5 Actavis Nordic A/S Recent Developments
    11.18 Albireo Pharma Inc
        11.18.1 Albireo Pharma Inc Corporation Information
        11.18.2 Albireo Pharma Inc Overview
        11.18.3 Albireo Pharma Inc IBS-C Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.18.4 Albireo Pharma Inc IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.18.5 Albireo Pharma Inc Recent Developments
    11.19 Yuhan Corp
        11.19.1 Yuhan Corp Corporation Information
        11.19.2 Yuhan Corp Overview
        11.19.3 Yuhan Corp IBS-C Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.19.4 Yuhan Corp IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.19.5 Yuhan Corp Recent Developments
    11.20 Astrazeneca Plc
        11.20.1 Astrazeneca Plc Corporation Information
        11.20.2 Astrazeneca Plc Overview
        11.20.3 Astrazeneca Plc IBS-C Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.20.4 Astrazeneca Plc IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.20.5 Astrazeneca Plc Recent Developments
    11.21 The Menarini Group
        11.21.1 The Menarini Group Corporation Information
        11.21.2 The Menarini Group Overview
        11.21.3 The Menarini Group IBS-C Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.21.4 The Menarini Group IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.21.5 The Menarini Group Recent Developments
    11.22 Ono Pharmaceutical Co., Ltd
        11.22.1 Ono Pharmaceutical Co., Ltd Corporation Information
        11.22.2 Ono Pharmaceutical Co., Ltd Overview
        11.22.3 Ono Pharmaceutical Co., Ltd IBS-C Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.22.4 Ono Pharmaceutical Co., Ltd IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.22.5 Ono Pharmaceutical Co., Ltd Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 IBS-C Drugs Industry Chain Analysis
    12.2 IBS-C Drugs Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 IBS-C Drugs Production Mode & Process
    12.4 IBS-C Drugs Sales and Marketing
        12.4.1 IBS-C Drugs Sales Channels
        12.4.2 IBS-C Drugs Distributors
    12.5 IBS-C Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 IBS-C Drugs Industry Trends
    13.2 IBS-C Drugs Market Drivers
    13.3 IBS-C Drugs Market Challenges
    13.4 IBS-C Drugs Market Restraints
14 Key Findings in The Global IBS-C Drugs Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global IBS-C Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Linaclotide
    Table 3. Major Manufacturers of Lubiprostone
    Table 4. Major Manufacturers of Osmotic Laxatives
    Table 5. Major Manufacturers of Stimulant Laxatives
    Table 6. Major Manufacturers of Others
    Table 7. Global IBS-C Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global IBS-C Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global IBS-C Drugs Sales by Region (2017-2022) & (K Pcs)
    Table 10. Global IBS-C Drugs Sales Market Share by Region (2017-2022)
    Table 11. Global IBS-C Drugs Sales by Region (2023-2028) & (K Pcs)
    Table 12. Global IBS-C Drugs Sales Market Share by Region (2023-2028)
    Table 13. Global IBS-C Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 14. Global IBS-C Drugs Revenue Market Share by Region (2017-2022)
    Table 15. Global IBS-C Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 16. Global IBS-C Drugs Revenue Market Share by Region (2023-2028)
    Table 17. Global IBS-C Drugs Sales by Manufacturers (2017-2022) & (K Pcs)
    Table 18. Global IBS-C Drugs Sales Share by Manufacturers (2017-2022)
    Table 19. Global IBS-C Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 20. Global IBS-C Drugs Revenue Share by Manufacturers (2017-2022)
    Table 21. IBS-C Drugs Price by Manufacturers (2017-2022) &(USD/Pcs)
    Table 22. Global IBS-C Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global IBS-C Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IBS-C Drugs as of 2021)
    Table 24. IBS-C Drugs Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers IBS-C Drugs Product Offered
    Table 26. Date of Manufacturers Enter into IBS-C Drugs Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global IBS-C Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 29. Global IBS-C Drugs Sales by Type (2023-2028) & (K Pcs)
    Table 30. Global IBS-C Drugs Sales Share by Type (2017-2022)
    Table 31. Global IBS-C Drugs Sales Share by Type (2023-2028)
    Table 32. Global IBS-C Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 33. Global IBS-C Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 34. Global IBS-C Drugs Revenue Share by Type (2017-2022)
    Table 35. Global IBS-C Drugs Revenue Share by Type (2023-2028)
    Table 36. IBS-C Drugs Price by Type (2017-2022) & (USD/Pcs)
    Table 37. Global IBS-C Drugs Price Forecast by Type (2023-2028) & (USD/Pcs)
    Table 38. Global IBS-C Drugs Sales by Application (2017-2022) & (K Pcs)
    Table 39. Global IBS-C Drugs Sales by Application (2023-2028) & (K Pcs)
    Table 40. Global IBS-C Drugs Sales Share by Application (2017-2022)
    Table 41. Global IBS-C Drugs Sales Share by Application (2023-2028)
    Table 42. Global IBS-C Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 43. Global IBS-C Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 44. Global IBS-C Drugs Revenue Share by Application (2017-2022)
    Table 45. Global IBS-C Drugs Revenue Share by Application (2023-2028)
    Table 46. IBS-C Drugs Price by Application (2017-2022) & (USD/Pcs)
    Table 47. Global IBS-C Drugs Price Forecast by Application (2023-2028) & (USD/Pcs)
    Table 48. North America IBS-C Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 49. North America IBS-C Drugs Sales by Type (2023-2028) & (K Pcs)
    Table 50. North America IBS-C Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 51. North America IBS-C Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 52. North America IBS-C Drugs Sales by Application (2017-2022) & (K Pcs)
    Table 53. North America IBS-C Drugs Sales by Application (2023-2028) & (K Pcs)
    Table 54. North America IBS-C Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 55. North America IBS-C Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 56. North America IBS-C Drugs Sales by Country (2017-2022) & (K Pcs)
    Table 57. North America IBS-C Drugs Sales by Country (2023-2028) & (K Pcs)
    Table 58. North America IBS-C Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 59. North America IBS-C Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 60. Europe IBS-C Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 61. Europe IBS-C Drugs Sales by Type (2023-2028) & (K Pcs)
    Table 62. Europe IBS-C Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 63. Europe IBS-C Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 64. Europe IBS-C Drugs Sales by Application (2017-2022) & (K Pcs)
    Table 65. Europe IBS-C Drugs Sales by Application (2023-2028) & (K Pcs)
    Table 66. Europe IBS-C Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 67. Europe IBS-C Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 68. Europe IBS-C Drugs Sales by Country (2017-2022) & (K Pcs)
    Table 69. Europe IBS-C Drugs Sales by Country (2023-2028) & (K Pcs)
    Table 70. Europe IBS-C Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 71. Europe IBS-C Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 72. Asia Pacific IBS-C Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 73. Asia Pacific IBS-C Drugs Sales by Type (2023-2028) & (K Pcs)
    Table 74. Asia Pacific IBS-C Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 75. Asia Pacific IBS-C Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 76. Asia Pacific IBS-C Drugs Sales by Application (2017-2022) & (K Pcs)
    Table 77. Asia Pacific IBS-C Drugs Sales by Application (2023-2028) & (K Pcs)
    Table 78. Asia Pacific IBS-C Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 79. Asia Pacific IBS-C Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 80. Asia Pacific IBS-C Drugs Sales by Region (2017-2022) & (K Pcs)
    Table 81. Asia Pacific IBS-C Drugs Sales by Region (2023-2028) & (K Pcs)
    Table 82. Asia Pacific IBS-C Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 83. Asia Pacific IBS-C Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 84. Latin America IBS-C Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 85. Latin America IBS-C Drugs Sales by Type (2023-2028) & (K Pcs)
    Table 86. Latin America IBS-C Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 87. Latin America IBS-C Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 88. Latin America IBS-C Drugs Sales by Application (2017-2022) & (K Pcs)
    Table 89. Latin America IBS-C Drugs Sales by Application (2023-2028) & (K Pcs)
    Table 90. Latin America IBS-C Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 91. Latin America IBS-C Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 92. Latin America IBS-C Drugs Sales by Country (2017-2022) & (K Pcs)
    Table 93. Latin America IBS-C Drugs Sales by Country (2023-2028) & (K Pcs)
    Table 94. Latin America IBS-C Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 95. Latin America IBS-C Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 96. Middle East and Africa IBS-C Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 97. Middle East and Africa IBS-C Drugs Sales by Type (2023-2028) & (K Pcs)
    Table 98. Middle East and Africa IBS-C Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 99. Middle East and Africa IBS-C Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa IBS-C Drugs Sales by Application (2017-2022) & (K Pcs)
    Table 101. Middle East and Africa IBS-C Drugs Sales by Application (2023-2028) & (K Pcs)
    Table 102. Middle East and Africa IBS-C Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa IBS-C Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa IBS-C Drugs Sales by Country (2017-2022) & (K Pcs)
    Table 105. Middle East and Africa IBS-C Drugs Sales by Country (2023-2028) & (K Pcs)
    Table 106. Middle East and Africa IBS-C Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa IBS-C Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 108. Catalent Pharmaceuticals Solutions Corporation Information
    Table 109. Catalent Pharmaceuticals Solutions Description and Major Businesses
    Table 110. Catalent Pharmaceuticals Solutions IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 111. Catalent Pharmaceuticals Solutions IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Catalent Pharmaceuticals Solutions Recent Developments
    Table 113. Nestle Corporation Information
    Table 114. Nestle Description and Major Businesses
    Table 115. Nestle IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 116. Nestle IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Nestle Recent Developments
    Table 118. Abbott Laboratories Corporation Information
    Table 119. Abbott Laboratories Description and Major Businesses
    Table 120. Abbott Laboratories IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 121. Abbott Laboratories IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Abbott Laboratories Recent Developments
    Table 123. Synergy Pharmaceuticals Corporation Information
    Table 124. Synergy Pharmaceuticals Description and Major Businesses
    Table 125. Synergy Pharmaceuticals IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 126. Synergy Pharmaceuticals IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Synergy Pharmaceuticals Recent Developments
    Table 128. Sucampo Pharmaceuticals Corporation Information
    Table 129. Sucampo Pharmaceuticals Description and Major Businesses
    Table 130. Sucampo Pharmaceuticals IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 131. Sucampo Pharmaceuticals IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Sucampo Pharmaceuticals Recent Developments
    Table 133. Novartis Pharma Ag Corporation Information
    Table 134. Novartis Pharma Ag Description and Major Businesses
    Table 135. Novartis Pharma Ag IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 136. Novartis Pharma Ag IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Novartis Pharma Ag Recent Developments
    Table 138. Astellas Pharmaceuticals Corporation Information
    Table 139. Astellas Pharmaceuticals Description and Major Businesses
    Table 140. Astellas Pharmaceuticals IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 141. Astellas Pharmaceuticals IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Astellas Pharmaceuticals Recent Developments
    Table 143. Ardelyx, Inc Corporation Information
    Table 144. Ardelyx, Inc Description and Major Businesses
    Table 145. Ardelyx, Inc IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 146. Ardelyx, Inc IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. Ardelyx, Inc Recent Developments
    Table 148. Synthetic Biologics, Inc Corporation Information
    Table 149. Synthetic Biologics, Inc Description and Major Businesses
    Table 150. Synthetic Biologics, Inc IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 151. Synthetic Biologics, Inc IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. Synthetic Biologics, Inc Recent Developments
    Table 153. Teva Pharmaceutical Industries Corporation Information
    Table 154. Teva Pharmaceutical Industries Description and Major Businesses
    Table 155. Teva Pharmaceutical Industries IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 156. Teva Pharmaceutical Industries IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. Teva Pharmaceutical Industries Recent Developments
    Table 158. Bama-Geve, SLU Corporation Information
    Table 159. Bama-Geve, SLU Description and Major Businesses
    Table 160. Bama-Geve, SLU IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 161. Bama-Geve, SLU IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 162. Bama-Geve, SLU Recent Developments
    Table 163. Ferring BV Corporation Information
    Table 164. Ferring BV Description and Major Businesses
    Table 165. Ferring BV IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 166. Ferring BV IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 167. Ferring BV Recent Developments
    Table 168. Ironwood Pharmaceuticals, Inc Corporation Information
    Table 169. Ironwood Pharmaceuticals, Inc Description and Major Businesses
    Table 170. Ironwood Pharmaceuticals, Inc IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 171. Ironwood Pharmaceuticals, Inc IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 172. Ironwood Pharmaceuticals, Inc Recent Developments
    Table 173. Salix Pharmaceuticals Ltd Corporation Information
    Table 174. Salix Pharmaceuticals Ltd Description and Major Businesses
    Table 175. Salix Pharmaceuticals Ltd IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 176. Salix Pharmaceuticals Ltd IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 177. Salix Pharmaceuticals Ltd Recent Developments
    Table 178. Norgine B.V Corporation Information
    Table 179. Norgine B.V Description and Major Businesses
    Table 180. Norgine B.V IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 181. Norgine B.V IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 182. Norgine B.V Recent Developments
    Table 183. Prometheus Laboratories Inc Corporation Information
    Table 184. Prometheus Laboratories Inc Description and Major Businesses
    Table 185. Prometheus Laboratories Inc IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 186. Prometheus Laboratories Inc IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 187. Prometheus Laboratories Inc Recent Developments
    Table 188. Actavis Nordic A/S Corporation Information
    Table 189. Actavis Nordic A/S Description and Major Businesses
    Table 190. Actavis Nordic A/S IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 191. Actavis Nordic A/S IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 192. Actavis Nordic A/S Recent Developments
    Table 193. Albireo Pharma Inc Corporation Information
    Table 194. Albireo Pharma Inc Description and Major Businesses
    Table 195. Albireo Pharma Inc IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 196. Albireo Pharma Inc IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 197. Albireo Pharma Inc Recent Developments
    Table 198. Yuhan Corp Corporation Information
    Table 199. Yuhan Corp Description and Major Businesses
    Table 200. Yuhan Corp IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 201. Yuhan Corp IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 202. Yuhan Corp Recent Developments
    Table 203. Astrazeneca Plc Corporation Information
    Table 204. Astrazeneca Plc Description and Major Businesses
    Table 205. Astrazeneca Plc IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 206. Astrazeneca Plc IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 207. Astrazeneca Plc Recent Developments
    Table 208. The Menarini Group Corporation Information
    Table 209. The Menarini Group Description and Major Businesses
    Table 210. The Menarini Group IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 211. The Menarini Group IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 212. The Menarini Group Recent Developments
    Table 213. Ono Pharmaceutical Co., Ltd Corporation Information
    Table 214. Ono Pharmaceutical Co., Ltd Description and Major Businesses
    Table 215. Ono Pharmaceutical Co., Ltd IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 216. Ono Pharmaceutical Co., Ltd IBS-C Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 217. Ono Pharmaceutical Co., Ltd Recent Developments
    Table 218. Key Raw Materials Lists
    Table 219. Raw Materials Key Suppliers Lists
    Table 220. IBS-C Drugs Distributors List
    Table 221. IBS-C Drugs Customers List
    Table 222. IBS-C Drugs Market Trends
    Table 223. IBS-C Drugs Market Drivers
    Table 224. IBS-C Drugs Market Challenges
    Table 225. IBS-C Drugs Market Restraints
    Table 226. Research Programs/Design for This Report
    Table 227. Key Data Information from Secondary Sources
    Table 228. Key Data Information from Primary Sources
List of Figures
    Figure 1. IBS-C Drugs Product Picture
    Figure 3. Global IBS-C Drugs Market Share by Type in 2021 & 2028
    Figure 3. Linaclotide Product Picture
    Figure 4. Lubiprostone Product Picture
    Figure 5. Osmotic Laxatives Product Picture
    Figure 6. Stimulant Laxatives Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global IBS-C Drugs Market Share by Application in 2021 & 2028
    Figure 9. Hospital Pharmacies
    Figure 10. Retail Pharmacies
    Figure 11. Online Pharmacies
    Figure 12. IBS-C Drugs Report Years Considered
    Figure 13. Global IBS-C Drugs Sales 2017-2028 (K Pcs)
    Figure 14. Global IBS-C Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global IBS-C Drugs Revenue 2017-2028 (US$ Million)
    Figure 16. Global IBS-C Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 17. Global IBS-C Drugs Sales Market Share by Region (2017-2022)
    Figure 18. Global IBS-C Drugs Sales Market Share by Region (2023-2028)
    Figure 19. North America IBS-C Drugs Sales YoY (2017-2028) & (K Pcs)
    Figure 20. North America IBS-C Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Europe IBS-C Drugs Sales YoY (2017-2028) & (K Pcs)
    Figure 22. Europe IBS-C Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Asia-Pacific IBS-C Drugs Sales YoY (2017-2028) & (K Pcs)
    Figure 24. Asia-Pacific IBS-C Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Latin America IBS-C Drugs Sales YoY (2017-2028) & (K Pcs)
    Figure 26. Latin America IBS-C Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Middle East & Africa IBS-C Drugs Sales YoY (2017-2028) & (K Pcs)
    Figure 28. Middle East & Africa IBS-C Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. The IBS-C Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 30. The Top 5 and 10 Largest Manufacturers of IBS-C Drugs in the World: Market Share by IBS-C Drugs Revenue in 2021
    Figure 31. Global IBS-C Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 32. Global IBS-C Drugs Sales Market Share by Type (2017-2028)
    Figure 33. Global IBS-C Drugs Revenue Market Share by Type (2017-2028)
    Figure 34. Global IBS-C Drugs Sales Market Share by Application (2017-2028)
    Figure 35. Global IBS-C Drugs Revenue Market Share by Application (2017-2028)
    Figure 36. North America IBS-C Drugs Sales Market Share by Type (2017-2028)
    Figure 37. North America IBS-C Drugs Revenue Market Share by Type (2017-2028)
    Figure 38. North America IBS-C Drugs Sales Market Share by Application (2017-2028)
    Figure 39. North America IBS-C Drugs Revenue Market Share by Application (2017-2028)
    Figure 40. North America IBS-C Drugs Sales Share by Country (2017-2028)
    Figure 41. North America IBS-C Drugs Revenue Share by Country (2017-2028)
    Figure 42. U.S. IBS-C Drugs Revenue (2017-2028) & (US$ Million)
    Figure 43. Canada IBS-C Drugs Revenue (2017-2028) & (US$ Million)
    Figure 44. Europe IBS-C Drugs Sales Market Share by Type (2017-2028)
    Figure 45. Europe IBS-C Drugs Revenue Market Share by Type (2017-2028)
    Figure 46. Europe IBS-C Drugs Sales Market Share by Application (2017-2028)
    Figure 47. Europe IBS-C Drugs Revenue Market Share by Application (2017-2028)
    Figure 48. Europe IBS-C Drugs Sales Share by Country (2017-2028)
    Figure 49. Europe IBS-C Drugs Revenue Share by Country (2017-2028)
    Figure 50. Germany IBS-C Drugs Revenue (2017-2028) & (US$ Million)
    Figure 51. France IBS-C Drugs Revenue (2017-2028) & (US$ Million)
    Figure 52. U.K. IBS-C Drugs Revenue (2017-2028) & (US$ Million)
    Figure 53. Italy IBS-C Drugs Revenue (2017-2028) & (US$ Million)
    Figure 54. Russia IBS-C Drugs Revenue (2017-2028) & (US$ Million)
    Figure 55. Asia Pacific IBS-C Drugs Sales Market Share by Type (2017-2028)
    Figure 56. Asia Pacific IBS-C Drugs Revenue Market Share by Type (2017-2028)
    Figure 57. Asia Pacific IBS-C Drugs Sales Market Share by Application (2017-2028)
    Figure 58. Asia Pacific IBS-C Drugs Revenue Market Share by Application (2017-2028)
    Figure 59. Asia Pacific IBS-C Drugs Sales Share by Region (2017-2028)
    Figure 60. Asia Pacific IBS-C Drugs Revenue Share by Region (2017-2028)
    Figure 61. China IBS-C Drugs Revenue (2017-2028) & (US$ Million)
    Figure 62. Japan IBS-C Drugs Revenue (2017-2028) & (US$ Million)
    Figure 63. South Korea IBS-C Drugs Revenue (2017-2028) & (US$ Million)
    Figure 64. India IBS-C Drugs Revenue (2017-2028) & (US$ Million)
    Figure 65. Australia IBS-C Drugs Revenue (2017-2028) & (US$ Million)
    Figure 66. Taiwan IBS-C Drugs Revenue (2017-2028) & (US$ Million)
    Figure 67. Indonesia IBS-C Drugs Revenue (2017-2028) & (US$ Million)
    Figure 68. Thailand IBS-C Drugs Revenue (2017-2028) & (US$ Million)
    Figure 69. Malaysia IBS-C Drugs Revenue (2017-2028) & (US$ Million)
    Figure 70. Philippines IBS-C Drugs Revenue (2017-2028) & (US$ Million)
    Figure 71. Latin America IBS-C Drugs Sales Market Share by Type (2017-2028)
    Figure 72. Latin America IBS-C Drugs Revenue Market Share by Type (2017-2028)
    Figure 73. Latin America IBS-C Drugs Sales Market Share by Application (2017-2028)
    Figure 74. Latin America IBS-C Drugs Revenue Market Share by Application (2017-2028)
    Figure 75. Latin America IBS-C Drugs Sales Share by Country (2017-2028)
    Figure 76. Latin America IBS-C Drugs Revenue Share by Country (2017-2028)
    Figure 77. Mexico IBS-C Drugs Revenue (2017-2028) & (US$ Million)
    Figure 78. Brazil IBS-C Drugs Revenue (2017-2028) & (US$ Million)
    Figure 79. Argentina IBS-C Drugs Revenue (2017-2028) & (US$ Million)
    Figure 80. Middle East and Africa IBS-C Drugs Sales Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa IBS-C Drugs Revenue Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa IBS-C Drugs Sales Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa IBS-C Drugs Revenue Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa IBS-C Drugs Sales Share by Country (2017-2028)
    Figure 85. Middle East and Africa IBS-C Drugs Revenue Share by Country (2017-2028)
    Figure 86. Turkey IBS-C Drugs Revenue (2017-2028) & (US$ Million)
    Figure 87. Saudi Arabia IBS-C Drugs Revenue (2017-2028) & (US$ Million)
    Figure 88. U.A.E IBS-C Drugs Revenue (2017-2028) & (US$ Million)
    Figure 89. IBS-C Drugs Value Chain
    Figure 90. IBS-C Drugs Production Process
    Figure 91. Channels of Distribution
    Figure 92. Distributors Profiles
    Figure 93. Bottom-up and Top-down Approaches for This Report
    Figure 94. Data Triangulation
    Figure 95. Key Executives Interviewed